Utilization and Disparity in Prostate Cancer Risk Assessment Tools with Dr. Michael Leapman, MD, MHS

2 Views
Published
Michael Leapman, MD, MHS, Associate Professor, Department of Urology, Yale University School of Medicine, New Haven, Connecticut, delivers a 9-minute presentation on disparities and utilization patterns of prostate cancer risk assessment tools. His talk provides essential insights into the challenges and opportunities in closing gaps in prostate cancer diagnostics, ensuring fair and comprehensive care for all populations.
Category
Urology
Be the first to comment